Coffee and caffeine dependence: What do we know now?

被引:0
|
作者
Nehlig, A [1 ]
机构
[1] Fac Med Strasbourg, INSERM, U398, F-67085 Strasbourg, France
来源
SEVENTEENTH INTERNATIONAL SCIENTIFIC COLLOQUIUM ON COFFEE, NAIROBI, JULY 20-25, 1997 | 1997年
关键词
D O I
暂无
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
Caffeine is the most widely used psychoactive substance in the world, Although it is usually consumed in rather modest amounts that induce mostly positive effects, caffeine has been considered incidentely as a drug of abuse or even a model of drug abuse. Therefore, the possibility that caffeine abuse, dependence and withdrawal should be added to diagnostic manuals has been considered in the United States. The present paper reviews the available data on caffeine dependence, reinforcement and withdrawal to try to assess in which respect caffeine differs from the classical drugs of abuse. After caffeine cessation, withdrawal symptoms develop in a large portion of the population but they are moderate and last only for a few days. Tolerance to the effects of caffeine on the central nervous system is very limited. Caffeine shows reinforcing properties but only at low doses while high doses induce dysphoric effects and are usually avoided. Conversely to the classical drugs of abuse which lead to quite specific increases in cerebral functional activity and dopamine release in the shell of the nucleus accumbens, the key structure for reward, motivation and addiction, caffeine does not primarily act at the level of that structure and increases glucose utilization in the shell of the nucleus accumbens only at rather high doses that stimulate most brain structures and are already somewhat aversive. In conclusion, although caffeine does share some features of dependence with classical drugs of abuse, they are not sufficient to consider that there is a strong dependence to caffeine in the general population.
引用
收藏
页码:35 / 42
页数:4
相关论文
共 50 条
  • [1] HYPERSEXUALITY: WHAT DO WE KNOW BY NOW?
    Azevedo, P. A.
    Ferreira Carvalho, R. F. C.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S392 - S393
  • [2] NOW THAT WE KNOW YOUTH, WHAT WILL WE DO ABOUT IT
    ESTY, JC
    PHI DELTA KAPPAN, 1976, 57 (06) : 418 - 419
  • [3] Swift-Certain-Fair What Do We Know Now, and What Do We Need to Know?
    Kleiman, Mark A. R.
    Criminology & Public Policy, 2016, 15 (04) : 1185 - 1193
  • [4] What do we know about retention now?
    Richardson, Lorna
    EDINBURGH LAW REVIEW, 2018, 22 (03) : 387 - 393
  • [5] Religion and democratisation: what do we now know?
    Haynes, Jeffrey
    JOURNAL OF RELIGIOUS AND POLITICAL PRACTICE, 2016, 2 (02) : 267 - 272
  • [6] Anthocyanins: What do we know until now?
    Giampieri, Francesca
    Cianciosi, Danila
    Alvarez-Suarez, Jose M.
    Quiles, Jose L.
    Forbes-Hernandez, Tamara Y.
    Navarro-Hortal, Maria D.
    Machi, Michele
    Pali Casanova, Ramon del Jesus
    Martinez Espinosa, Julio Cesar
    Chen, Xiumin
    Di Zhang
    Bai, Weibin
    Tian Lingmin
    Mezzetti, Bruno
    Battino, Maurizio
    Diaz, Yasmany Armas
    JOURNAL OF BERRY RESEARCH, 2023, 13 (01) : 1 - 6
  • [7] The Dawn of Mitophagy: What Do We Know by Now?
    Belousov, Dmitrii M.
    Mikhaylenko, Elizaveta, V
    Somasundaram, Siva G.
    Kirkland, Cecil E.
    Aliev, Gjumrakch
    CURRENT NEUROPHARMACOLOGY, 2021, 19 (02) : 170 - 192
  • [8] Pyoderma Gangrenosum: What Do We Know Now?
    McKenzie F.
    Arthur M.
    Ortega-Loayza A.G.
    Current Dermatology Reports, 2018, 7 (3) : 147 - 157
  • [9] Treatment as prevention trials and ending AIDS: what do we know, when did we know it, and what do we do now?
    Granich, Reuben
    Williams, Brian G.
    CURRENT OPINION IN HIV AND AIDS, 2019, 14 (06) : 514 - 520
  • [10] Coffee and digestive cancers—what do we know, and where do we go?
    Erikka Loftfield
    Neal D. Freedman
    British Journal of Cancer, 2020, 122 : 1273 - 1274